Paper41799343
The role of miRNAs in the development of brain metastases originating from lung adenocarcinoma.
Torner B and 7 others. Front Genet, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The role of miRNAs in the development of brain metastases originating from lung adenocarcinoma. Papers, record 41799343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41799343
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of miRNAs in the development of brain metastases originating from lung adenocarcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29364287 | The biology and management of non-small cell lung cancer. | Nature | 2018 | https://conductscience.org/library/papers/29364287 | PubMed |
| 2 | 26199015 | miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers. | Clin Transl Oncol | 2016 | https://conductscience.org/library/papers/26199015 | PubMed |
| 3 | 24486218 | MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. | Cancer Lett | 2014 | https://conductscience.org/library/papers/24486218 | PubMed |
| 4 | 17898713 | Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. | Nature | 2007 | https://conductscience.org/library/papers/17898713 | PubMed |
| 5 | 33450361 | Anti-PD-(L)1 immunotherapy for brain metastases in non-small cell lung cancer: Mechanisms, advances, and challenges. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33450361 | PubMed |
| 6 | 38398086 | Hypoxia-Derived Exosomes Promote Lung Adenocarcinoma by Regulating HS3ST1-GPC4-Mediated Glycolysis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38398086 | PubMed |
| 7 | 17565689 | Characterization of microRNA expression profiles in normal human tissues. | BMC Genomics | 2007 | https://conductscience.org/library/papers/17565689 | PubMed |
| 8 | 28727734 | MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1. | PLoS One | 2017 | https://conductscience.org/library/papers/28727734 | PubMed |
| 9 | 40002176 | Construction of a miRNA Panel for Differentiating Lung Adenocarcinoma Brain Metastases and Glioblastoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40002176 | PubMed |
| 10 | 29321091 | The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression. | Oncol Res | 2018 | https://conductscience.org/library/papers/29321091 | PubMed |
| 11 | 35658112 | Hypoxia-induced miR-210-3p expression in lung adenocarcinoma potentiates tumor development by regulating CCL2 mediated monocyte infiltration. | Mol Oncol | 2024 | https://conductscience.org/library/papers/35658112 | PubMed |
| 12 | 32186774 | miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway. | Oncol Rep | 2020 | https://conductscience.org/library/papers/32186774 | PubMed |
| 13 | 36821071 | MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy. | J Appl Genet | 2023 | https://conductscience.org/library/papers/36821071 | PubMed |
| 14 | 26883804 | Neurotrophin signaling in cancer stem cells. | Cell Mol Life Sci | 2016 | https://conductscience.org/library/papers/26883804 | PubMed |
| 15 | 33339421 | Immune Checkpoint Inhibitors with or without Radiotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/33339421 | PubMed |
| 16 | 38149244 | Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers. | Front Immunol | 2023 | https://conductscience.org/library/papers/38149244 | PubMed |
| 17 | 24874051 | MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R. | Tumour Biol | 2014 | https://conductscience.org/library/papers/24874051 | PubMed |
| 18 | 38568412 | Machine learning-driven prediction of brain metastasis in lung adenocarcinoma using miRNA profile and target gene pathway analysis of an mRNA dataset. | Clin Transl Oncol | 2024 | https://conductscience.org/library/papers/38568412 | PubMed |
| 19 | 39859424 | MicroRNA-200c in Cancer Generation, Invasion, and Metastasis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859424 | PubMed |
| 20 | 24066071 | MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. | PLoS One | 2013 | https://conductscience.org/library/papers/24066071 | PubMed |
Genes44
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41799343
GET https://conductscience.org/api/papers/v1/41799343/references?page=2